Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT05768139
Phase 1
Recruiting
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
United States, Belgium, France, Germany, Ireland, Italy, Japan, Netherlands, Spa
NCT05307705
Phase 1
Active, not recruiting
A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
United States, Australia, Belgium, Canada, China, France, Germany, Japan, Singap